Evidence map›Paper›PMID 36851310›Full record

ArticleVaccines2023

Factors Contributing to Chronic Kidney Disease following COVID-19 Diagnosis in Pre-Vaccinated Hospitalized Patients.

Diana Laila Ramatillah, Michael Michael, Kashifullah Khan, Nia Natasya, Elizabeth Sinaga, Silvy Hartuti, Nuzul Fajriani, Muhammad Junaid Farrukh, Siew Hua Gan

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Diana Laila RamatillahFaculty of Pharmacy, Universitas 17 Agustus 1945 Jakarta, North Jakarta 14350, Indonesia.ORCID 0000-0002-3921-3455
Michael MichaelFaculty of Pharmacy, Universitas 17 Agustus 1945 Jakarta, North Jakarta 14350, Indonesia.ORCID 0000-0003-0207-0275
Kashifullah KhanDepartment of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail 2440, Saudi Arabia.
Nia NatasyaFaculty of Pharmacy, Universitas 17 Agustus 1945 Jakarta, North Jakarta 14350, Indonesia.
Elizabeth SinagaFaculty of Pharmacy, Universitas 17 Agustus 1945 Jakarta, North Jakarta 14350, Indonesia.
Silvy HartutiFaculty of Pharmacy, Universitas 17 Agustus 1945 Jakarta, North Jakarta 14350, Indonesia.
Nuzul FajrianiFaculty of Pharmacy, Universitas 17 Agustus 1945 Jakarta, North Jakarta 14350, Indonesia.
Muhammad Junaid FarrukhFaculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur 56000, Malaysia.
Siew Hua GanSchool of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway 47500, Malaysia.ORCID 0000-0001-6470-3651
Universitas 17 Agustus 1945 Jakarta · IDMonash University Malaysia · MYUCSI University · MYUniversity of Ha'il · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we aim to evaluate the factors that may contribute to the development of chronic kidney disease following COVID-19 infection among hospitalized patients in two private hospitals in Jakarta, Indonesia. This is a retrospective cohort study between March 2020 and September 2021. Patient selection was conducted with a convenience sampling. All patients (n = 378) meeting the inclusion criteria during the study period were enrolled. Various sociodemographic, laboratory test, and diagnostic parameters were measured before the determination of their correlation with the outcome of COVID-19 infection. In this study, all pre-vaccinated patients with COVID-19 had no history of chronic kidney disease (CKD) prior to hospital admission. From this number, approximately 75.7% of the patients developed CKD following COVID-19 diagnosis. Overall, significant correlations were established between the clinical outcome and the CKD status (

Indexed as

CKDCOVID-19ICUsurvival rate

Identifiers

PMID36851310
PMCPMC9966430
OpenAlexW4320728430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.